Manufacture of peanut formulations for oral desensitization
US10449118B2 · kind B2 · utility
6Cited by
4References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 24, 2017 |
| Grant date | Oct 22, 2019 |
| Priority date | — |
| Expiry date | Oct 24, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/542
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application relates to a method for managing the development and manufacturing process of a therapeutically effective formulation. Peanut proteins are characterized from peanut flour and encapsulated formulations made using the peanut flour for oral immunotherapy of peanut allergies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.